Humana (HUM) was downgraded to underperform by BofA, which cited an ongoing delay in margin recovery amid news the company ...
Between the escalating conflict in the Middle East and the lead up to the U.S. presidential election, investors have had a ...
Analyst Erin Wright of Morgan Stanley maintained a Hold rating on Humana (HUM – Research Report), with a price target of $374.00. Erin ...
Medicare Advantage quality ratings for the company dropped, meaning a big drop in revenue from bonus payments.